Article
Improving Selection Criteria for ALK Inhibitor Therapy in Non-Small Cell Lung Cancer: A Pooled-Data Analysis on Diagnostic Operating Characteristics of Immunohistochemistry.
The American journal of surgical pathology - 1 May 2016
Jiang Long, Yang Haihong, He Ping, Liang Wenhua, Zhang Jianrong, Li Jingpei, Liu Yang, He Jianxing
Abstract excerpt
Lung cancer is often diagnosed by molecular markers for prediction and treatment. To date, the golden standard for detection of anaplastic lymphoma kinase (ALK) rearrangements is fluorescence in situ hybridization (FISH). We performed a pooled-data analysis on the diagnostic operating characteristics of immunohistochemistry (IHC) assay on non-small cell lung cancer (NSCLC). We searched Embase, Pubmed, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.